![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pfizer Hit With Class Action Lawsuits Alleging Generic Celebrex Delay
Pfizer Hit With Class Action Lawsuits Alleging Generic Celebrex Delay
Pfizer is facing at least three class action lawsuits alleging that the company went to extraordinary, fraudulent lengths to maintain exclusivity over its multibillion dollar arthritis pain drug Celebrex and keep generic competitors off the market.
Generic Line
Drugs Commercial OperationsGeneric Line
Upcoming Events
-
21Oct